[1] SIEGEL R,MILLER K D,JEMAL A.Cancer statistics,2018[J].CA Cancer J Clin,2018,68(1):7-30.
[2] BAST R C Jr,HENNESSY B,MILLS G B.The biology of ovarian cancer:New opportunities for translation[J].Nat Rev Cancer,2009,9(6):415-428.
[3] VAUGHAN S,COWARD J I,BAST R C Jr,et al.Rethinking ovarian cancer:Recommendations for improving outcomes[J].Nat Rev Cancer,2011,11(10):719-725.
[4] BAST R C Jr,KLUG T L,ST JOHN E,et al.A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer[J].N Engl J Med,1983,309(15):883-887.
[5] 张曦匀,帕提曼·米吉提,古扎丽努尔·阿不力孜.常用肿瘤标志物在上皮性卵巢癌诊断中的临床价值[J].中国现代医学杂志,2017,27(15):62-67.
[6] 唐洁,王蕾.术后CA125值变化对上皮性卵巢癌预后判断的价值[J].中国现代医学杂志,2012,22(7):39-43.
[7] ROSSI A C,DI VAGNO G,CORMIO G,et al.A retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer[J].Arch Gynecol Obstet,2004,269(4):263-265.
[8] SEVELDA P,SCHEMPER M,SPONA J.CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer[J].Am J Obstet Gynecol,1989,161(5):1213-1216.
[9] HOGDALL E V,CHRISTENSEN L,KJAER S K,et al.CA125 expression pattern,prognosis and correlation with serum CA125 in ovarian tumor patients.From The Danish "MALOVA" Ovarian Cancer Study[J].Gynecol Oncol,2007,104(3):508-515.
[10] GADDUCCI A,ZOLA P,LANDONI F,et al.Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer:Results of a multicentric Italian study[J].Gynecol Oncol,1995,58(1):42-47.
[11] GEISLER J P,MILLER G A,LEE T H,et al.Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma[J].J Reprod Med,1996,41(3):140-142.
[12] NAGELE F,PETRU E,MEDL M,et al.Preoperative CA 125:An independent prognostic factor in patients with stage Ⅰ epithelial ovarian cancer[J].Obstet Gynecol,1995,86(2):259-264.
[13] 邱建,傅云峰,周彩云,等.上皮性卵巢癌组织CK2β和p53蛋白表达临床意义分析[J].中华肿瘤防治杂志,2015,22(6):451-456.
[14] CHAN J K,CHEUNG M K,HUSAIN A,et al.Patterns and progress in ovarian cancer over 14 years[J].Obstet Gynecol,2006,108(3 Pt 1):521-528.
[15] MAY T,STEWART J M,BERNARDINI M Q,et al..The prognostic value of perioperative,pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer[J].Int J Gynecol Obstet,2018,140(2):247-252.
[16] 秦雪,刘鑫丽,王欣彦,等.血清CA125变化与上皮性卵巢癌预后及复发关系研究[J].中国实用妇科与产科杂志,2016,32(5):473-476. |